Media Statement: LabCorp continues to increase capacity for COVID-19 molecular and serological tests

Labcorp to webcast its annual meeting of shareholders

BURLINGTON, N.C. --(BUSINESS WIRE)--May 5, 2020-- LabCorp (NYSE: LH) today announced that its Annual Meeting of Shareholders will be webcast live beginning May 13 , at 9:00 a.m. Eastern Daylight Time via the company website at www.LabCorp.com. An archived replay of the audio webcast will be

LabCorp Announces 2020 First Quarter Results

Q1 revenue of $2.82 billion , up 1% over $2.79 billion last year Q1 diluted EPS of ( $3.27 ), which include goodwill and other asset impairments of $4.43 per share Q1 adjusted EPS of $2.37 , which were negatively impacted by an estimated $0.55 per share from the COVID-19 pandemic Q1 free cash flow

Ruth Heim, PhD, FACMG

Dr Heim is currently a diplomate of the American Board of Medical Genetics and Genomics and a fellow of the American College of Medical Genetics. She is certified by the New York State Department of Health as a director of genetic testing (molecular) and molecular and cellular tumor markers. Dr Heim graduated from the University of the Witwatersrand, South Africa, with a First Class BSc(Hons) degree and a PhD in human molecular genetics. She completed postdoctoral fellowship training in clinical molecular genetics at the University of North Carolina Chapel Hill.